Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 491 Rectal Neoplasms 267 Colonic Neoplasms 218 Pancreatic Neoplasms 186 Stomach Neoplasms 181 Esophageal Neoplasms 134 Breast Neoplasms 118 Neoplasm Metastasis 116 Squamous Cell Carcinoma of Head and Neck 94 Head and Neck Neoplasms 92 Neoplasms 88 Adenocarcinoma Of Esophagus 67 Esophageal Squamous Cell Carcinoma 61 Carcinoma, Hepatocellular 54 Adenocarcinoma 40 Nasopharyngeal Carcinoma 33 Cholangiocarcinoma 32 Biliary Tract Neoplasms 26 Anus Neoplasms 26 Gastrointestinal Neoplasms 25 Carcinoma, Squamous Cell 25 Carcinoma, Non-Small-Cell Lung 25 Keratosis, Actinic 22 Gallbladder Neoplasms 21 Urinary Bladder Neoplasms 20 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Liver Neoplasms 20 Bile Duct Neoplasms 19 Ovarian Neoplasms 16 Carcinoma 16

Interventions

Fentanyl 23 Analgesia 22 Morphine 19 Acupuncture Therapy 18 Zoledronic Acid 15 Oxycodone 14 Acetaminophen 14 Ketamine 13 Radiotherapy 12 Therapeutics 11 Methadone 11 Lidocaine 11 nabiximols 10 Ibandronic Acid 10 Hydromorphone 10 Bupivacaine 10 Surveys and Questionnaires 8 Ropivacaine 8 Psychiatric Rehabilitation 7 Early Intervention, Educational 7 Saline Solution 6 Music Therapy 6 Cryotherapy 6 Cryosurgery 6 Yoga 5 Water 5 Tapentadol 5 Pregabalin 5 Methods 5 Massage 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain × Fluorouracil × Clear all

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡